Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jul;35(7):955–960. doi: 10.1136/gut.35.7.955

Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.

L Manzano 1, M Alvarez-Mon 1, J A Vargas 1, J A Girón 1, L Abreu 1, A Fernández-Corugedo 1, L I Román 1, F Albarran 1, A Durántez 1
PMCID: PMC1374844  PMID: 8063224

Abstract

There is increasing evidence that ulcerative colitis is associated with an abnormality of the immune system. Although the aetiology remains unknown, it has been suggested that the immune system of these patients is implicated in the pathogenesis of their disease. T cell function was investigated in ulcerative colitis patients and defective phytohaemagglutinin induced T cell mitogenesis was found. The DNA synthesis induced by stimulation with phorbol esters plus ionophore (ionomycin), however, was normal. These changes cannot be ascribed to either decreased interleukin 2 synthesis or to a defective interleukin 2 receptor expression after cellular activation. Moreover, this defective proliferative response of the T lymphocytes was observed even in the presence of saturated concentrations of exogenous interleukin 2. These results emphasise that the interleukin 2 dependent proliferation pathway is deficient in T lymphocytes from ulcerative colitis patients.

Full text

PDF
955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aas J., Huizenga A., Newcomer A. D., Shorter R. G. Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro. Scand J Gastroenterol. 1972;7(4):299–303. doi: 10.3109/00365527209180746. [DOI] [PubMed] [Google Scholar]
  2. Allison J. P., Lanier L. L. Structure, function, and serology of the T-cell antigen receptor complex. Annu Rev Immunol. 1987;5:503–540. doi: 10.1146/annurev.iy.05.040187.002443. [DOI] [PubMed] [Google Scholar]
  3. Alvarez de Mon M., Casas J., Laguna R., Toribio M. L., de Landázuri M. O., Durántez A. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL. Blood. 1986 Jan;67(1):228–232. [PubMed] [Google Scholar]
  4. Alvarez-Mon M., de la Hera A., Gaspar M. L., Orfao A., Casas J., Jordá J., Durantez A. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor. Acta Haematol. 1989;81(2):91–97. doi: 10.1159/000205533. [DOI] [PubMed] [Google Scholar]
  5. Asquith P., Kraft S. C., Rothberg R. M. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease. Gastroenterology. 1973 Jul;65(1):1–7. [PubMed] [Google Scholar]
  6. Bull D. M., Ignaczak T. F. Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. Gastroenterology. 1973 Jan;64(1):43–50. [PubMed] [Google Scholar]
  7. Chatila T., Wong R., Young M., Miller R., Terhorst C., Geha R. S. An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med. 1989 Mar 16;320(11):696–702. doi: 10.1056/NEJM198903163201104. [DOI] [PubMed] [Google Scholar]
  8. Ebert E. C., Wright S. H., Lipshutz W. H., Hauptman S. P. T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2. Clin Immunol Immunopathol. 1984 Nov;33(2):232–244. doi: 10.1016/0090-1229(84)90078-3. [DOI] [PubMed] [Google Scholar]
  9. Fiocchi C., Hilfiker M. L., Youngman K. R., Doerder N. C., Finke J. H. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology. 1984 Apr;86(4):734–742. [PubMed] [Google Scholar]
  10. Gaspar M. L., Alvarez-Mon M., Gutierrez C. The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings. J Clin Immunol. 1988 Jul;8(4):266–274. doi: 10.1007/BF00916555. [DOI] [PubMed] [Google Scholar]
  11. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  12. Kusugami K., Youngman K. R., West G. A., Fiocchi C. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology. 1989 Jul;97(1):1–9. doi: 10.1016/0016-5085(89)91408-x. [DOI] [PubMed] [Google Scholar]
  13. Larsson E. L., Iscove N. N., Coutinho A. Two distinct factors are required for induction of T-cell growth. Nature. 1980 Feb 14;283(5748):664–666. doi: 10.1038/283664a0. [DOI] [PubMed] [Google Scholar]
  14. Lyanga J. J., Davis P., Thomson A. B. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin Exp Immunol. 1979 Jul;37(1):120–125. [PMC free article] [PubMed] [Google Scholar]
  15. MacDermott R. P., Bragdon M. J., Thurmond R. D. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis. Gastroenterology. 1984 Mar;86(3):476–484. [PubMed] [Google Scholar]
  16. MacDermott R. P., Stenson W. F. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol. 1988;42:285–328. doi: 10.1016/s0065-2776(08)60848-2. [DOI] [PubMed] [Google Scholar]
  17. Manzano L., Alvarez-Mon M., Abreu L., Antonio Vargas J., de la Morena E., Corugedo F., Duràntez A. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2. Gut. 1992 Feb;33(2):246–251. doi: 10.1136/gut.33.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Menéndez J. L., Girón J. A., Manzano L., Garrido A., Abreu L., Albillos A., Durántez A., Alvarez-Mon M. Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis. Hepatology. 1992 Oct;16(4):931–936. doi: 10.1002/hep.1840160413. [DOI] [PubMed] [Google Scholar]
  19. Mills G. B., Lee J. W., Cheung R. K., Gelfand E. W. Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin. J Immunol. 1985 Nov;135(5):3087–3093. [PubMed] [Google Scholar]
  20. Ming R. H., Atluru D., Spellman C. W., Imir T., Goodwin J. S., Strickland R. G. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol. 1987 Jan;7(1):59–63. doi: 10.1007/BF00915426. [DOI] [PubMed] [Google Scholar]
  21. Miura M., Hiwatashi N. Cytokine production in inflammatory bowel disease. J Clin Lab Immunol. 1985 Oct;18(2):81–86. [PubMed] [Google Scholar]
  22. Mullin G. E., Lazenby A. J., Harris M. L., Bayless T. M., James S. P. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology. 1992 May;102(5):1620–1627. doi: 10.1016/0016-5085(92)91722-g. [DOI] [PubMed] [Google Scholar]
  23. Schwartz R. H. Antigen presentation: fugue in T-lymphocyte recognition. Nature. 1987 Apr 23;326(6115):738–739. doi: 10.1038/326738a0. [DOI] [PubMed] [Google Scholar]
  24. Schwartz R. H. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol. 1985;3:237–261. doi: 10.1146/annurev.iy.03.040185.001321. [DOI] [PubMed] [Google Scholar]
  25. Strober W., James S. P. The immunologic basis of inflammatory bowel disease. J Clin Immunol. 1986 Nov;6(6):415–432. doi: 10.1007/BF00915248. [DOI] [PubMed] [Google Scholar]
  26. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Targan S. R., Kagnoff M. F., Brogan M. D., Shanahan F. Immunologic mechanisms in intestinal diseases. Ann Intern Med. 1987 Jun;106(6):853–870. doi: 10.7326/0003-4819-106-6-853. [DOI] [PubMed] [Google Scholar]
  28. Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES